Ann: Licensing Webinar and Presentation, page-10

I've bought more, averaged up and doubled my position size after this webinar.

Some general thoughts from me:

• All dilution/capital raise risk has been removed until interim
• Interim results significantly re-rates the company into a $100-200M market cap
• Strong body of evidence supports CBD effect on sleep
• Santos due diligence was extensive - they have seen enough to be convinced to punt provide upfront payment
• Chart setup looks bullish - major turn around in sentiment
• Similar to DXB I expect we will see further licensing deals before interim result which will continue to serve as re-rate catalyst
• Paul is very proud, he has been in the trenches for years and has proven that he can negotiate strong deals.
• JFK Jr is pro cannabis - the US market is now very attractive.

The share price will take care of it self from here, if it sells off or not doesn't bother me because true value will be reflected as each of these milestones get hit.

Huge congratulations to all shareholders here and well done to Paul and his team.